
doi: 10.1038/nm.3279
pmid: 23836200
The ability to patent human genes has been costly to researchers and patients, and has restricted competition in the biotech marketplace. The recent US Supreme Court decision making isolated human genes unpatentable will bring freedom of choice to the patient, and level the playing field for research and development.
Ovarian Neoplasms, Biomedical Research, Legislation, Medical, Carcinoma, DNA Mutational Analysis, Genes, BRCA2, Genes, BRCA1, Breast Neoplasms, United States, Ethics, Research, Patents as Topic, Patient Rights, Genes, Humans, Female, Supreme Court Decisions, Early Detection of Cancer
Ovarian Neoplasms, Biomedical Research, Legislation, Medical, Carcinoma, DNA Mutational Analysis, Genes, BRCA2, Genes, BRCA1, Breast Neoplasms, United States, Ethics, Research, Patents as Topic, Patient Rights, Genes, Humans, Female, Supreme Court Decisions, Early Detection of Cancer
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
